Nuveen Asset Management, LLC Relay Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 275,106 shares of RLAY stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
275,106
Previous 446,808 38.43%
Holding current value
$1.28 Million
Previous $2.91 Million 33.16%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$6.23 - $9.51 $1.07 Million - $1.63 Million
-171,702 Reduced 38.43%
275,106 $1.95 Million
Q2 2024

Aug 09, 2024
BUY
$5.9 - $8.02 $1.09 Million - $1.48 Million
184,925 Added 70.61%
446,808 $2.91 Million
Q4 2023

Feb 14, 2024
BUY
$6.01 - $11.48 $20,512 - $39,181
3,413 Added 1.32%
261,883 $2.88 Million
Q3 2023

Nov 14, 2023
SELL
$8.24 - $12.97 $13,282 - $20,907
-1,612 Reduced 0.62%
258,470 $2.17 Million
Q2 2023

Aug 14, 2023
BUY
$9.99 - $18.27 $91,358 - $167,079
9,145 Added 3.64%
260,082 $3.27 Million
Q1 2023

May 15, 2023
BUY
$15.0 - $22.76 $236,010 - $358,105
15,734 Added 6.69%
250,937 $4.13 Million
Q4 2022

Feb 14, 2023
SELL
$14.16 - $24.02 $551,886 - $936,179
-38,975 Reduced 14.22%
235,203 $3.51 Million
Q3 2022

Nov 14, 2022
BUY
$18.07 - $31.37 $78,279 - $135,894
4,332 Added 1.61%
274,178 $6.13 Million
Q2 2022

Aug 15, 2022
BUY
$13.31 - $34.88 $699,081 - $1.83 Million
52,523 Added 24.17%
269,846 $4.52 Million
Q1 2022

May 16, 2022
BUY
$20.26 - $32.36 $106,810 - $170,601
5,272 Added 2.49%
217,323 $5.63 Million
Q4 2021

Feb 14, 2022
SELL
$26.0 - $37.03 $56,342 - $80,244
-2,167 Reduced 1.01%
212,051 $5.93 Million
Q3 2021

Nov 12, 2021
BUY
$29.75 - $37.99 $199,533 - $254,798
6,707 Added 3.23%
214,218 $7.95 Million
Q2 2021

Aug 16, 2021
BUY
$27.5 - $38.19 $1.4 Million - $1.95 Million
50,977 Added 32.57%
207,511 $7.59 Million
Q1 2021

May 17, 2021
BUY
$32.52 - $61.53 $905,454 - $1.71 Million
27,843 Added 21.64%
156,534 $5.41 Million
Q4 2020

Feb 16, 2021
BUY
$35.51 - $54.03 $94,172 - $143,287
2,652 Added 2.1%
128,691 $5.35 Million
Q3 2020

Nov 16, 2020
BUY
$32.81 - $45.1 $4.14 Million - $5.68 Million
126,039 New
126,039 $5.37 Million

Others Institutions Holding RLAY

# of Institutions
204
Shares Held
156M
Call Options Held
207K
Put Options Held
40K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $560M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email